Compare JCSE & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JCSE | ACON |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | Singapore | United States |
| Employees | N/A | 11 |
| Industry | Miscellaneous manufacturing industries | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 7.4M |
| IPO Year | 2022 | N/A |
| Metric | JCSE | ACON |
|---|---|---|
| Price | $1.41 | $2.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 6.9K | ★ 39.3K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | ★ 8.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $1.95 |
| 52 Week High | $2.50 | $12.03 |
| Indicator | JCSE | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 52.67 | N/A |
| Support Level | $1.22 | N/A |
| Resistance Level | $1.50 | N/A |
| Average True Range (ATR) | 0.10 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 55.00 | 0.00 |
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.